Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
While the prevalence of SLD and its subcategories remained stable, there was a significant increase in advanced fibrosis among SLD individuals during the COVID-19 era, with ALD having a proportion of advanced fibrosis and cirrhosis that was twice as high as MASLD and MetALD.
Authors
- Karn Wijarnpreecha (ORCID: https://orcid.org/0000-0002-6232-6343)
- Rohit Seth Loomba (ORCID: https://orcid.org/0000-0002-4845-9991)
- Pojsakorn Danpanichkul (ORCID: https://orcid.org/0000-0002-9121-165X)
- George T. Cholankeril (ORCID: https://orcid.org/0000-0001-5335-8426)
- Aijaz Ahmed (ORCID: https://orcid.org/0000-0002-3609-8586)
- Donghee Kim (ORCID: https://orcid.org/0000-0003-1919-6800)
Institutions
- Texas Tech University (US)
- University of Arizona (US)
- Baylor College of Medicine (US)
- University of California San Diego (US)
- Banner - University Medical Center Phoenix (US)
- Banner - University Medical Center Tucson (US)
- Texas Tech University Health Sciences Center (US)
- Stanford University (US)
Publication Details
- Journal
- Clinical and Molecular Hepatology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.3350/cmh.2024.0987
- Citations
- 46
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 17.78